Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ovarian cancer patients at high risk of BRCA mutation: the constitutional genetic characterization does not change prognosis.

Familial cancer - 1 Oct 2016

Sabatier Renaud, Lavit Elise, Moretta Jessica, Lambaudie Eric, Noguchi Tetsuro, Eisinger François, Cherau Elisabeth, Provansal Magali, Livon Doriane, Rabayrol Laetitia, Popovici Cornel, Charaffe-Jauffret Emmanuelle, Sobol Hagay, Viens Patrice

Abstract excerpt

Ovarian neoplasms secondary to germline BRCA mutations had been described to have a more favourable survival. There is only few data concerning the prognosis of non mutated patients presenting clinical features evocative of BRCA alterations. We retrospectively collected data from patients treated in our institution for an invasive ovarian carcinoma between 1995 and 2011. Patients considered at high risk of BRCA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Disease-Free Survival

Share to Germ-Line Mutation

Share to Mutation

Share to Ovarian Neoplasms

Share to Prognosis

Source

Identifiers

PMID: 26833043
DOI: 10.1007/s10689-016-9873-9

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ovarian cancer patients at high risk of BRCA mutation: the constitutional genetic characterization does not change prognosis.PMID 26833043Read ↗

Beyond the BRCA1/2 genes in ovarian cancer: the clinical and prognostic role of germline pathogenic variants in the ATM geneSemantic proximity Read ↗

Frequency of germline mutations in BRCA1 and BRCA2 in ovarian cancer patients and their effect on treatment outcomeSemantic proximity Read ↗

Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1).Semantic proximity Read ↗

Prediction of BRCA1/2 mutation status in patients with ovarian cancer from a hospital-based cohort.Semantic proximity Read ↗

[Characteristics of selected features of hereditary ovarian cancer in carriers of constitutional BRCA1 gene mutation].Semantic proximity Read ↗

Risk factors and prognostic factors in patients with double primary cancer: epithelial ovarian cancer and breast cancer.Semantic proximity Read ↗

BRCA1/2 and clinical outcome in a monoinstitutional cohort of women with hereditary breast cancer.Semantic proximity Read ↗

Clinical characteristics of hereditary ovarian cancer (HOC) in Poland.Semantic proximity Read ↗

Limited significance of family history for presence of BRCA1 gene mutation in Polish breast and ovarian cancer cases.Semantic proximity Read ↗

Characteristics and outcome of BRCA mutated epithelial ovarian cancer patients in Italy: A retrospective multicenter study (MITO 21).Semantic proximity Read ↗

Prognostic Significance of Clinical Factors Including BRCA Mutation in Epithelial Ovarian, Peritoneal, Fallopian Tube Cancer.Semantic proximity Read ↗

[Clinical-based study of ovarian cancer patients with and without BRCA1/2 genes mutation: clinical features and pedigree analysis].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.